Clinical Trials for CS Bio

Explore 16 clinical trials worldwide

Showing 1-16 of 16 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CS Bio

Clinical Trials (16)

NCT07156253
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
110 participants
Started: Aug 26, 2025 · Completed: Feb 25, 2029
5 conditions1 sponsor2 locations
NCT07088588
Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1Not yet recruiting
105 participants
Started: Jul 31, 2025 · Completed: Oct 31, 2028
6 conditions1 sponsor2 locations
NCT06689423
Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay
N/ANot yet recruiting
2,000 participants
Started: Nov 30, 2024 · Completed: Apr 30, 2025
4 conditions2 sponsors1 location
NCT06666270
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1Recruiting
30 participants
Started: Nov 21, 2024 · Completed: Dec 30, 2026
7 conditions1 sponsor2 locations
NCT06728189
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
PHASE1Recruiting
13 participants
Started: Nov 14, 2024 · Completed: Oct 17, 2026
1 condition2 sponsors1 location
NCT05833724
Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)
PHASE2Recruiting
33 participants
Started: Oct 18, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT06153212
Regenerative Treatment of Peri-implantitis
NAEnrolling by invitation
32 participants
Started: Nov 2, 2023 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT05924906
A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors
PHASE1Not yet recruiting
30 participants
Started: Oct 31, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor0 locations
NCT05958121
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
PHASE1/PHASE2Recruiting
145 participants
Started: Aug 9, 2023 · Completed: Sep 30, 2027
4 conditions1 sponsor24 locations
NCT05837143
Myocardial Telomere Recapping Study for Dilated Cardiomyopathy
EARLY_PHASE1Active, not recruiting
12 participants
Started: Mar 30, 2023 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT05651100
Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma
PHASE1/PHASE2Not yet recruiting
50 participants
Started: Dec 10, 2022 · Completed: Dec 10, 2025
1 condition2 sponsors1 location
NCT05359445
IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor
PHASE1Recruiting
95 participants
Started: May 19, 2022 · Completed: Dec 31, 2029
4 conditions1 sponsor23 locations
NCT06141928
Comparison of Three Different Surgical Approaches on the Functional Outcome After Total Hip Arthroplasty
NARecruiting
100 participants
Started: Sep 1, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04445844
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study
PHASE2Active, not recruiting
25 participants
Started: Jul 13, 2020 · Completed: Jun 30, 2025
5 conditions4 sponsors2 locations
NCT04215146
A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study
PHASE2Active, not recruiting
48 participants
Started: Jun 10, 2020 · Completed: Jun 30, 2025
1 condition2 sponsors18 locations
NCT04327791
COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)
PHASE2/PHASE3Recruiting
60 participants
Started: Apr 3, 2020 · Completed: Jun 1, 2025
1 condition3 sponsors3 locations